These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 20883991)

  • 1. Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue.
    Bayoglu Tekin Y; Dilbaz B; Altinbas SK; Dilbaz S
    Fertil Steril; 2011 Feb; 95(2):492-6. PubMed ID: 20883991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis.
    Petta CA; Ferriani RA; Abrao MS; Hassan D; Rosa E Silva JC; Podgaec S; Bahamondes L
    Hum Reprod; 2005 Jul; 20(7):1993-8. PubMed ID: 15790607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis].
    Deng S; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):664-8. PubMed ID: 17199919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis.
    Ozdegirmenci O; Kayikcioglu F; Akgul MA; Kaplan M; Karcaaltincaba M; Haberal A; Akyol M
    Fertil Steril; 2011 Feb; 95(2):497-502. PubMed ID: 21074150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of levonorgestrel-releasing intrauterine system in treatment of recurrent endometriosis after conservative surgery].
    Xu XW; Zhang YW; He FF; Wang LD; Guan YT; Sun J; Lin M; Hu Y
    Zhonghua Fu Chan Ke Za Zhi; 2011 Apr; 46(4):250-4. PubMed ID: 21609576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of levonorgestrel-releasing intrauterine system combined with GnRH analogue for treatment of large adenomyosis].
    Zheng Z; Wang NN; Wang JH; Gan XQ; Zheng QQ; Ke PQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):541-3, 546. PubMed ID: 20335132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The levonorgestrel-releasing intrauterine system and endometriosis staging.
    Gomes MK; Ferriani RA; Rosa e Silva JC; Japur de Sá Rosa e Silva AC; Vieira CS; Cândido dos Reis FJ
    Fertil Steril; 2007 May; 87(5):1231-4. PubMed ID: 17292364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea.
    Bahamondes L; Petta CA; Fernandes A; Monteiro I
    Contraception; 2007 Jun; 75(6 Suppl):S134-9. PubMed ID: 17531605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial.
    Tanmahasamut P; Rattanachaiyanont M; Angsuwathana S; Techatraisak K; Indhavivadhana S; Leerasiri P
    Obstet Gynecol; 2012 Mar; 119(3):519-26. PubMed ID: 22314873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of the levonorgestrel-releasing intrauterine device in the treatment of recurrent pelvic pain in multitreated endometriosis.
    Matorras R; Ballesteros A; Prieto B; Ocerin I; Expósito A; Pijoan JI; Crisol L
    J Reprod Med; 2011; 56(11-12):497-503. PubMed ID: 22195333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Levonorgestrel-releasing intrauterine system for treatment of dysmenorrhea associated with adenomyosis].
    Sheng J; Lu D; Zhang JP; Cui GF
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):467-70. PubMed ID: 17083813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 3-year follow-up of women with endometriosis and pelvic pain users of the levonorgestrel-releasing intrauterine system.
    Petta CA; Ferriani RA; Abrão MS; Hassan D; Rosa e Silva JC; Podgaec S; Bahamondes L
    Eur J Obstet Gynecol Reprod Biol; 2009 Apr; 143(2):128-9. PubMed ID: 19181433
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue.
    Ferreira RA; Vieira CS; Rosa-E-Silva JC; Rosa-e-Silva AC; Nogueira AA; Ferriani RA
    Contraception; 2010 Feb; 81(2):117-22. PubMed ID: 20103448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicated intrauterine systems for treatment of endometriosis-associated pain.
    Muzii L
    J Minim Invasive Gynecol; 2006; 13(6):535-8. PubMed ID: 17097576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy of diegnogest and levonorgestrel-releasing intrauterine system after laparoscopic surgery for endometriosis.
    Lee KH; Jung YW; Song SY; Kang BH; Yang JB; Ko YB; Lee M; Han HY; Yoo HJ
    J Obstet Gynaecol Res; 2018 Sep; 44(9):1779-1786. PubMed ID: 29974633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial.
    Carvalho N; Margatho D; Cursino K; Benetti-Pinto CL; Bahamondes L
    Fertil Steril; 2018 Nov; 110(6):1129-1136. PubMed ID: 30396557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel-releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients.
    Morelli M; Sacchinelli A; Venturella R; Mocciaro R; Zullo F
    J Obstet Gynaecol Res; 2013 May; 39(5):985-90. PubMed ID: 23551827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a role for use of levonorgestrel intrauterine system in women with chronic pelvic pain?
    Anpalagan A; Condous G
    J Minim Invasive Gynecol; 2008; 15(6):663-6. PubMed ID: 18774757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up.
    Lockhat FB; Emembolu JO; Konje JC
    Hum Reprod; 2005 Mar; 20(3):789-93. PubMed ID: 15608040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
    Sheng J; Zhang WY; Zhang JP; Lu D
    Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.